Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Negative and Cognitive Symptoms in Early-Phase Schizophrenia
NCT00733057Phase 3Completed
- Sponsor
- Shalvata Mental Health Center
- Start
- Aug 2003
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in schizophrenia, sponsored by Shalvata Mental Health Center. Started Aug 2003; status: completed.
02
Drugs
minocycline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00733057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00733057.